You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0633 Epratuzumab-treated SLE patients report improvements in health-related quality of life: Interim results from a us open-label extension study

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
SLE, Sjögren’s and APS – treatment
AB0633 Epratuzumab-treated SLE patients report improvements in health-related quality of life: Interim results from a us open-label extension study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Strand V, Kalunian K, Wallace D, et al
AB0633 Epratuzumab-treated SLE patients report improvements in health-related quality of life: Interim results from a us open-label extension study
Annals of the Rheumatic Diseases 2013;71:675.